Author Archives: MAIN ADMIN

Protein ZMYND8 tied to suppression of prostate cancer tumor metastasis

PUBLIC RELEASE: 28-JUL-2016 [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Study reveals protein’s ability to block expression of metastasis-linked genes UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER PUBLIC RELEASE: 28-JUL-2016 Although it reads like European license plate number, a protein known as ZMYND8 has demonstrated its ability to block metastasis-linked genes in prostate cancer, according to a study at…

Switch from observation only to active treatment by prostate cancer patients varies by race/ethnicity

New York, NY, July 27, 2016 [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Assessment of clinical and nonclinical factors indicates that black men on active surveillance are more likely to pursue active treatment, according to a new study published in The Journal of Urology® ELSEVIER HEALTH SCIENCES Although active surveillance, or watchful waiting, for patients with low risk…

Prostate Cancer Isn’t Colorblind

By LANNIS HALL, ARNOLD D. BULLOCK, ANGELA L. BROWN and GRAHAM COLDITZJULY 27, 2016 [ultimate_spacer height=”32″]Full Article [ultimate_spacer height=”32″]   St. Louis — In 1966, the Rev. Dr. Martin Luther King Jr. said, “Of all the forms of inequality, injustice in health care is the most shocking and inhuman.” While major advances have been made in…

Era of Precision Oncology for Prostate Cancer ‘Is Upon Us’

July 10, 2016 Bryant Furlow [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] New biomarkers might revolutionize prostate cancer treatment, according to an educational presentation at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.1“We are now entering an era of personalized prostate cancer therapy informed by treatment-specific biomarkers, some of which can be performed using a…

PROSTATE CANCER ADVISOR: Familial Risk of Aggressive Prostate Cancer Quantified

Natasha Persaud, Digital Content Editor July 14, 2016 [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Swedish researchers have provided new estimates of the hereditary risk of significant prostate cancers (PCa) that may aid in patient counseling. Clinicians have long known that having a father or brother with
PCa doubles a man’s risk for the disease, but many of these
cancers…

Photoacoustic Imaging may improve prostate cancer monitoring and treatment

14-Jul-2016 8:05 AM [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Newswise — BUFFALO, N.Y. — While active surveillance is often recommended for patients with nonaggressive prostate cancer to reduce unnecessary treatment, the challenge for clinicians is to monitor and distinguish early-stage tumors from advanced cancers. A team of scientists led by researchers from Roswell Park Cancer Institute have…

Genetic testing can help deliver precision medicine to men with advanced prostate cancer

Date:July 7, 2016 [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Genetic testing in men with advanced prostate cancer could pick up a significant proportion whose disease may be caused by inherited mutations in genes involved in repairing DNA damage, a major new study reveals. Testing prostate cancer patients for mutations in key DNA repair genes could identify those…

Leading researchers recommend major change in prostate cancer treatment

Laurie McGinley July 6 [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Leading American and British cancer researchers are urging that all men with advanced prostate cancer strongly consider being tested for inherited gene mutations — both to help steer their treatment and to alert family members who themselves might be at increased risk for a range of cancers. This…